112 related articles for article (PubMed ID: 32986209)
1. Analysis of Bone Tissue Condition in Patients with Diffuse Large B-Cell Lymphoma without Bone Marrow Involvement.
Fastova EA; Magomedova AU; Kravchenko SK; Petinati NA; Sats NV; Drize NI; Savchenko VG
Bull Exp Biol Med; 2020 Sep; 169(5):677-682. PubMed ID: 32986209
[TBL] [Abstract][Full Text] [Related]
2. Bone Marrow Multipotent Mesenchymal Stromal Cells in Patients with Diffuse Large B-Cell Lymphoma.
Fastova EA; Magomedova AU; Petinati NA; Sats NV; Kapranov NM; Davydova YO; Drize NI; Kravchenko SK; Savchenko VG
Bull Exp Biol Med; 2019 May; 167(1):150-153. PubMed ID: 31183651
[TBL] [Abstract][Full Text] [Related]
3. Humoral Effect of a B-Cell Tumor on the Bone Marrow Multipotent Mesenchymal Stromal Cells.
Petinati NA; Bigildeev AE; Karpenko DS; Sats NV; Kapranov NM; Davydova YO; Fastova EA; Magomedova AU; Kravchenko SK; Arapidi GP; Rusanova MI; Lagarkova MM; Drize NI; Savchenko VG
Biochemistry (Mosc); 2021 Feb; 86(2):207-216. PubMed ID: 33832419
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow vascular endothelial growth factor level per platelet count might be a significant predictor for the treatment outcomes of patients with diffuse large B-cell lymphomas.
Kim JS; Gang GW; Lee SR; Sung HJ; Park Y; Kim DS; Choi CW; Kim BS
Jpn J Clin Oncol; 2015 Oct; 45(10):914-20. PubMed ID: 26185139
[TBL] [Abstract][Full Text] [Related]
5. Alterations in multipotent mesenchymal stromal cells from the bone marrow of acute myeloid leukemia patients at diagnosis and during treatment.
Shipounova IN; Petinati NA; Bigildeev AE; Sorokina TV; Kuzmina LA; Parovichnikova EN; Savchenko VG
Leuk Lymphoma; 2019 Aug; 60(8):2042-2049. PubMed ID: 30668205
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Importance of Bone Marrow Uptake on Baseline
Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
[TBL] [Abstract][Full Text] [Related]
7. Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study.
Shane E; Rodino MA; McMahon DJ; Addesso V; Staron RB; Seibel MJ; Mancini D; Michler RE; Lo SH
J Heart Lung Transplant; 1998 Nov; 17(11):1089-96. PubMed ID: 9855448
[TBL] [Abstract][Full Text] [Related]
8. Bone Marrow Molecular Markers Associated with Relapsed/Refractory Activated B-Cell-Like Diffuse Large B-Cell Lymphoma.
Wang D; Liu P; Zhang Y; Liu HY; Shen D; Che YQ
Biomed Res Int; 2018; 2018():1042597. PubMed ID: 30534553
[TBL] [Abstract][Full Text] [Related]
9. Case Report Diffuse large B-cell lymphoma in the primary bone marrow.
Hu Y; Chen SL; Huang ZX; Gao W; An N
Genet Mol Res; 2015 Jun; 14(2):6247-50. PubMed ID: 26125825
[TBL] [Abstract][Full Text] [Related]
10. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
Longobardi S; Di Rella F; Pivonello R; Di Somma C; Klain M; Maurelli L; Scarpa R; Colao A; Merola B; Lombardi G
J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
[TBL] [Abstract][Full Text] [Related]
11. Physiological Hypoxia (Physioxia) Impairs the Early Adhesion of Single Lymphoma Cell to Marrow Stromal Cell and Extracellular Matrix. Optical Tweezers Study.
Duś-Szachniewicz K; Drobczyński S; Ziółkowski P; Kołodziej P; Walaszek KM; Korzeniewska AK; Agrawal A; Kupczyk P; Woźniak M
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29949925
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D Deficiency and Its Influence on Bone Metabolism and Density in a Brazilian Population of Healthy Men.
Moreira ML; Neto LV; Madeira M; Lopes RF; Farias MLF
J Clin Densitom; 2018; 21(1):91-97. PubMed ID: 28233710
[TBL] [Abstract][Full Text] [Related]
13. High Ki-67 expression in involved bone marrow predicts worse clinical outcome in diffuse large B cell lymphoma patients treated with R-CHOP therapy.
Song MK; Chung JS; Lee JJ; Yang DH; Kim IS; Shin DH; Shin HJ
Int J Hematol; 2015 Feb; 101(2):140-7. PubMed ID: 25504496
[TBL] [Abstract][Full Text] [Related]
14. Associations of Bone Mineral Density and Bone Metabolism Indices with Urine Albumin to Creatinine Ratio in Chinese Patients with Type 2 Diabetes.
Zhao X; Zhang XM; Yuan N; Yu XF; Ji LN
Exp Clin Endocrinol Diabetes; 2019 Jan; 127(1):50-55. PubMed ID: 30396213
[TBL] [Abstract][Full Text] [Related]
15. Serum insulin/like growth factor I, bone mineral density and biochemical markers of bone metabolism in children with idiopathic osteoporosis.
Chlebna-Sokol D; Rusinska A
Endocr Regul; 2001 Dec; 35(4):201-8. PubMed ID: 11858767
[TBL] [Abstract][Full Text] [Related]
16. [Expression of Cdc7 and mcm2 as a marker for proliferation and prognosis in diffuse large B cell lymphoma].
Hou Y; Wang HQ; Fu K; Zhang HL; Qian ZZ; Qiu LH; Li W; Zhou SY; Li LF; Hao XS
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):911-5. PubMed ID: 22340100
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mice overexpressing macrophage migration inhibitory factor (MIF) exhibit high-turnover osteoporosis.
Onodera S; Sasaki S; Ohshima S; Amizuka N; Li M; Udagawa N; Irie K; Nishihira J; Koyama Y; Shiraishi A; Tohyama H; Yasuda K
J Bone Miner Res; 2006 Jun; 21(6):876-85. PubMed ID: 16753018
[TBL] [Abstract][Full Text] [Related]
18. The role of BMP-7 in chondrogenic and osteogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in vitro.
Shen B; Wei A; Whittaker S; Williams LA; Tao H; Ma DD; Diwan AD
J Cell Biochem; 2010 Feb; 109(2):406-16. PubMed ID: 19950204
[TBL] [Abstract][Full Text] [Related]
19. Tonsil-Derived Mesenchymal Stem Cells Promote Bone Mineralization and Reduce Marrow and Visceral Adiposity in a Mouse Model of Senile Osteoporosis.
Kim YH; Park M; Cho KA; Kim BK; Ryu JH; Woo SY; Ryu KH
Stem Cells Dev; 2016 Aug; 25(15):1161-71. PubMed ID: 27245267
[TBL] [Abstract][Full Text] [Related]
20. Acquired factor VIII inhibitor in a patient with malignant lymphoma.
Wenz B; Friedman G
Am J Med Sci; 1974 Nov; 268(5):295-9. PubMed ID: 4617504
[No Abstract] [Full Text] [Related]
[Next] [New Search]
